Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,051–1,100 of 2,455 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04476459	Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL	unknown	Phase 1 / Phase 2	33	Huiqiang HuangOTHER	1	Mar 15, 2021	clinicaltrials
NCT04796688	Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies	unknown	Phase 1	27	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	Mar 15, 2021